QTI Overview

QT Imaging Holdings, Inc. is a medical device company engaged in the research, development, and commercialization of body imaging systems using low-frequency sound waves. The Company's products include QTI Breast Acoustic CT Scanner and QTviewer Software. QTI’s Breast Acoustic CT scanner with QTViewer viewer software is the only three-dimensional (3D) imaging device to receive United States Food and Drug Administration (FDA) clearance for use as a transmission and reflection ultrasonic imaging system of a patients breast. QTviewer is its proprietary image viewing and analysis platform, purpose-built to interpret the rich, quantitative datasets generated by the QTI Breast Acoustic CT™ scanner. The QTviewer allows users to rotate, zoom, and cross-navigate entire breast volumes. Whether isolating lesions or exploring architectural distortion, radiologists can interact with the data dynamically to gain an understanding of tissue structure and lesion morphology.

Wall Street analysts forecast QTI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for QTI is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

QT Imaging Holdings Inc revenue for the last quarter amounts to 6.53M USD, increased 133.35

QT Imaging Holdings Inc. EPS for the last quarter amounts to -0.25 USD, decreased -79.34

QT Imaging Holdings Inc (QTI) has 32 emplpoyees as of May 15 2026.

Today QTI has the market capitalization of 80.81M USD.